Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
72%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
MEDX.TO
22
HOLDINGS
83%
ALSO IN LMAX.TO
LMAX.TO
22
HOLDINGS
75%
ALSO IN MEDX.TO
SECTOR DRIFT (MEDX.TO minus LMAX.TO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX.TO |
Weight in LMAX.TO |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.5% | 5.5% | 5.5% |
|
BRISTOL-MYERS SQUIBB CO | 5.1% | 5.2% | 5.1% |
|
JOHNSON & JOHNSON | 5.1% | 5.0% | 5.0% |
|
VERTEX PHARMACEUTICALS INC | 5.2% | 5.0% | 5.0% |
|
ABBVIE INC | 5.0% | 5.4% | 5.0% |
MEDX.TO Overweight Relative to LMAX.TO
 |
NOVO-NORDISK A/S-SPONS ADR | 6.3% |
 |
ASTRAZENECA PLC | 5.2% |
 |
NOVARTIS AG | 5.1% |
|
MERCK & CO. INC. | 0.4% |
|
VERTEX PHARMACEUTICALS INC | 0.2% |
|
PFIZER INC | 0.2% |
|
JOHNSON & JOHNSON | 0.1% |
|
INTUITIVE SURGICAL INC | 0.1% |
|
DANAHER CORP | 0.1% |
|
ELI LILLY & CO | 0.0% |
MEDX.TO Underweight Relative to LMAX.TO
|
UNITEDHEALTH GROUP INC | -7.3% |
|
CVS CAREMARK CORP | -6.8% |
|
CIGNA CORPORATION | -5.5% |
|
MCKESSON CORP | -4.5% |
|
BOSTON SCIENTIFIC CORP | -4.1% |
|
ABBVIE INC | -0.4% |
|
ABBOTT LABORATORIES | -0.2% |
|
STRYKER CORP | -0.2% |
|
BRISTOL-MYERS SQUIBB CO | 0.0% |
|
AMGEN INC | 0.0% |